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sensing in aqueous saline media and biofluids†
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Alicja Siennicka,a Pavel A. Levkin, c Manfred M. Kappes ab
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Non-covalent chemosensing ensembles of cucurbit[n]urils (CBn) have been widely used in proof-of-
concept sensing applications, but they are prone to disintegrate in saline media, e.g. biological fluids. We
show here that covalent cucurbit[7]uril–indicator dye conjugates are buffer- (10 PBS buffer) and saline-
stable (up to 1.4 M NaCl) and allow for selective sensing of Parkinson's drug amantadine in human urine
and saliva, where the analogous non-covalent CB7Idye complex is dysfunctional. The in-depth analysis
of the covalent host–dye conjugates in the gas-phase, and deionized versus saline aqueous media
revealed interesting structural, thermodynamic and kinetic effects that are of general interest for the
design of CBn-based supramolecular chemosensors and systems. This work also introduces a novel
high-affinity indicator dye for CB7 through which fundamental limitations of indicator displacement
assays (IDA) were exposed, namely an impractical slow equilibration time. Unlike non-covalent CBnIdye
reporter pairs, the conjugate chemosensors can also operate through a SN2-type guest–dye exchange
mechanism, which shortens assay times and opens new avenues for tailoring analyte-selectivity.Introduction
Emission based detection and analysis under the use of
supramolecular assemblies, namely host–guest combinations,
has become an extensively investigated research eld in the last
decades. Supramolecular complexes were widely investigated
regarding their use in the elds of drug detection1–3 and enzy-
matic reaction monitoring.4,5 For spectroscopically silent ana-
lytes, several methods such as indicator displacement assays
(IDA), where a dye is rst bound to a host and then replaced by
a guest, were developed.6–10 Among the various available host
systems for analyte detection, cucurbit[n]urils (CBn), which are
glycoluril-based macrocyclic hosts, have become popular
building blocks for chemosensors on account of their water
solubility, and their wide applicability in binding indicators and
biorelevant analytes.11–13 Although CBn-based chemosensors
possess advantageous high binding affinities and fast binding
kinetics for many biorelevant small molecules in deionizedlsruhe Institute of Technology (KIT),
enstein-Leopoldshafen, Germany. E-mail:
ruhe Institute of Technology (KIT), Fritz-
s – Functional Molecular Systems (IBCS-
(KIT), Hermann-von-Helmholtz Platz 1,
tion (ESI) available. See DOI:
3
water,14–16 the non-covalent interaction between host and guest
is strongly modulated by salts due to competitive17 (or cooper-
ative)18 cation binding to the carbonyl-fringed CBn portals.
Besides, non-covalent CBnIdye reporter pairs – as any bimo-
lecular non-covalent complex – are inherently prone to disso-
ciate upon dilution. Therefore, many reported CBn-based
chemosensors are operational for sensing applications in
deionized water or “minimal buffers” but were oen not suit-
able for applications in saline media or biouids, especially if
their salt concentration is varying from sample to sample
(matrix effects).19,20 We recently demonstrated that the use of
a high-affinity dye for CB8 enabled the detection of the drug
memantine in blood serum by IDA.21 However, this approach
can have severe fundamental limitations, e.g. for CB7-based
assays, that are discussed further below.
Consequently, integrating the indicator and receptor into
a single, non-dissociable unimolecular chemosensor appears to
be a promising alternative design strategy to overcome dilution
issues and to reduce the effect of salts on the chemosensor
performance in biouids. For instance, emissive naphthalene
units were installed as cavity walls in de novo cucurbit[n]uril-
derivatives,22 which thereby were functional in human urine for
detecting addictive over-the-counter drugs.23
Unimolecular host–dye conjugates based on cucurbit[7]uril
macrocycles would be promising chemosensors on account of
CB7's exceptionally high binding affinity for many hydrophobic
or cationic bioactive molecules such as steroids and poly-
amines,16,24 that can reach up to astonishing 1015 M1 forThis journal is © The Royal Society of Chemistry 2020

























































































View Article Onlineadamantane derivatives.25 The underlying driving force for
these outstanding binding affinities is the interplay of high-
energy water release from inside of the cavity26 and hydro-
phobic interactions of guest and inner cavity, hydrogen bond
formation and electrostatic interactions of the carbonyl-fringed
rims with cationic groups on the guest.2,27,28
Herein, we present unimolecular CB7-based chemosensors
with hydrophilic and exible linkers that allow for self-
encapsulation of the indicator dye in the host cavity (Fig. 1a).Results
Design and synthesis of CB7–dye conjugates
Through synthetic advances, it is now feasible to synthesize
mono-functionalized CB7 (ref. 29–34) with chemically reactive
groups, that allow for the covalent attachment of dye molecules.
For instance, CB7 was covalently linked to tetramethylrhod-
amine and the resulting conjugate showed CB7-like binding
properties for typical CB7–guests.35 A carboxyuorescein-
labeled CB7 chemosensor was reported for DNA sensing by
using Förster resonance energy transfer (FRET).36 Cyanine-3
(Cy3) covalently labeled CB7 (CB7-Cy3) was utilized for the
monitoring of single-vesicle fusion assays,37 protein bioimag-
ing,38 visualizations of autophagosome-lysosome fusion,39 and
investigation of cellular uptake and excretion pathways.40
However, such CB7–dye conjugates were connected by short
linkers which can't enable the self-encapsulation of the dye into
the CB7 cavity. Consequently, the signal change upon guest
binding was modest35 or an additional, non-covalently bound
indicator dye was required,36 respectively. Several different
uorescent reporter dyes are known for CB7,41 out of which
many are pKa shi-dyes, e.g. acridine dyes42 and quinone-imine
dyes.43 These dyes typically become protonated and thereby
show enhanced emission intensity upon inclusion in the CB7
cavity that is known to stabilize positively charged species. Such
pKa shi dyes work well in buffered aqueous media of a denedFig. 1 (a) Schematic representation of analyte-induced conforma-
tional changes of CB7–dye conjugates that can be detected by
emission spectroscopy; (b) schematic representation of the equilib-
rium between free- and bound-formation of CB7–dye with/without
linker in the presence of a high concentration of interferents.
This journal is © The Royal Society of Chemistry 2020pH, however, undesirable matrix-dependent signal variations
are found when biological uids of a varying pH, e.g. urine, are
used. In this work, berberine was selected as an indicator dye
because it shows a large intensity enhancement on inclusion in
CB7,44 a high binding constant of 107 M1 in deionized water45
and is chemically functionalizable through a demethylation-
alkylation procedure (Scheme 1a).46 Ethylene glycol-based
linkers were chosen as relatively hydrophilic and exible
connectors between CB7 and berberine moieties.47 Chemical
modeling suggested that a linker length of at least four ethylene
glycol units is necessary to enable the entry into and exit of the
berberine dye from the CB7 cavity. Thus, hexaethylene glycol
(HEG) and tetraethylene glycol (TEG) were utilized as linkers to
evaluate the effect of the linker-length.
The host–dye conjugates cucurbit[7]uril-HEG-berberine (1)
and cucurbit[7]uril-TEG-berberine (2) were prepared through
a convergent synthetic route shown in Scheme 1. To keep the
number of synthetic steps with CB7-species to a minimum, the
HEG or TEG linkers were attached to the berberine moiety,
resulting in azide terminated berberine-hexaethylene glycol-
azide (BC-HEG-N3) or berberine-tetraethylene glycol-azide (BC-
TEG-N3) conjugates (see Scheme 1a). The conjugates are then
coupled to alkyne-functionalized CB7 by a Huisgen 1,3-dipolar
cycloaddition (see Scheme 1c), which was selected because of its
good reactivity and lack of side products. Specically, BC-HEG-
N3 and BC-TEG-N3 were prepared through a three-step proce-
dure from commercial berberine hydrochloride (see ESI† for
details) in overall 54% yield on a 50 mg scale, and mono-
propargyloxylated CB7 (CB7-(Opr)1) was synthesized in a two-
step hydroxylation-alkylation procedure48 with an overall yield
of 5% on a 20 mg scale. The modest yield is in accordance with
the literature, but fortunately not problematic because CB7 can
be readily prepared at a gram scale. Purication of the BC-HEG-
N3 and BC-TEG-N3 dye-linker conjugates was performed by ash
column chromatography on silica, while mono-
propargyloxylated CB7 was obtained via mono-hydroxylated
CB7 which was puried through CHP20P resin columns.
Coupling of BC-HEG-N3 or BC-TEG-N3 with CB7-(Opr)1 was then
performed in DMSO/H2O (v/v¼ 55/45) in the presence of CuSO4
and L-ascorbate. The purication of chemosensor 1 and 2 was
carried out by HPLC on a preparative scale with a C18 column
and a mixture of acetonitrile and 0.1% triuoroacetic acid (TFA)
aqueous (v/v ¼ 1/3) as a solvent to remove unreacted starting
material and catalyst.Characterization and conformation of CB7–dye conjugates
The supramolecular behaviour of the CB7-linker-BC conjugates
was characterized by advanced mass spectrometry experiments,
1H NMR, absorbance, and emission spectroscopy to evaluate if
the CB7-linker-BC conjugates adopt the intended self-bound,
“folded” conformation (shown in Fig. 1a), or if the linkers
impose constraints. For simplicity, we focus the following
description on chemosensor 1 and refer the reader to the ESI†
for the corresponding results of chemosensor 2. In order to get
an insight into the inherent conformation of complex 1 in the
absence of solvent effects, ion mobility spectrometry wasChem. Sci., 2020, 11, 11142–11153 | 11143
Scheme 1 Synthesis routes of (a) berberine-HEG/TEG-azide, (b) mono-propargyl cucurbit[7]uril, (c) chemosensor 1 and 2 and (d) chemical
structure of all guests.

























































































View Article Onlineperformed. For chemosensor 1, the parent peak appeared atm/z
925.3130 as dicationic species and can be assigned as (1 + Na)2+
(see Fig. S24a† in the ESI). This species showed a dri time of
5.62 ms in the ion mobilogram, converting to a cross-section of
410 A2 (Fig. 2a).
The uniform, symmetric curve shape indicated that only one
dened conformation, i.e. the folded or unbound state occurs in
the gas-phase, but not a mixture of both. Upon addition of the
guest, 1-adamantanol, the characteristic complex was found at
m/z 1001.368 and was assigned as ((1 + 1-adamantanol) + Na)2+
(Fig. 2b). This species shows now a much larger dri time of
5.94 ms and a corresponding cross-section of 424A2 in the ion
mobilogram. The relatively large increase in the cross-section
upon guest binding can be understood by the displacement of
the bound BC moiety and the unfolding of the conformation.
For comparison, if chemosensor 1 would have occurred in its
unfolded conformation in the gas phase, then guest inclusion
into the cavity of CB7 would have not affected the BC moiety,
and the dri time would have remained almost the same.49 For
the analogous chemosensor 2 with the shorter TEG-linker, the
ion mobilogram shows two peaks in dri time (4.87 and 5.17
ms) that likely both adopt folded conformations but may differ
in the penetration depth of the BC moiety into the CB7 cavity
(Fig. S24c†). Upon addition of 1-adamantanol, unfolding ofFig. 2 (a) The ion mobilogram of 1 in the absence and presence of 1-
adamantanol shows an increase in collision cross-section (CCS) upon
dye displacement in the inclusion complex. (b) ESI-MS of 1 in the
presence of 1-adamantanol in positive ion mode.
11144 | Chem. Sci., 2020, 11, 11142–11153chemosensor 2 occurs (see Fig. S24c and d† in the ESI) as is
evidenced by the appearance of a single peak at a signicantly
higher dri time (5.66 ms).
Experiments in water were carried out to investigate if
unimolecular, self-folding of the CB7–dye conjugates also
occurs in solution. The 1H NMR spectrum of 1 in D2O shows
three sets of peak areas that can be assigned to the aromatic
peaks from the BC moiety (marked with red numbers) to the
CB7 host, and the HEG linker (Fig. 3). The singlet at 8.10 ppm
(marked with a green square) conrms that the click reaction
has proceeded to form a triazole-moiety. Furthermore, by
comparing with the 1H NMR spectrum of the corresponding BC-
HEG-N3 compound before click reaction, it becomes clear that
the aromatic protons of 1 exhibited both strong upeld and
downeld shis. In analogy to literature reports,44 this can be
interpreted by the inclusion of the 1,3-benzodioxole moiety of
BC into the CB7 cavity (shielding region of CBn hosts),44,50 while
the isoquinolinium moiety resides in the deshielding carbonyl-
fringed portal region of the host. Similar conclusions can be
drawn for chemosensor 2, see Fig. S18† for the analogous 1H
NMR spectra analysis. Notably, the 1H NMR spectra of 2 shows
broader peaks in the folded conformation than that of 1, indi-
cating that the distribution of conformers of 2 is present in
solution. This nding agrees with conformer distribution seen
in the ion mobilogram of folded 2. Aer the addition of
amantadine to the solution of 1 or 2, the aromatic protons of the
berberine moiety were shied in a way that indicates displace-
ment of the BC moiety from the host cavity (Fig. 3 and S18†).
Note also the characteristic differences in the chemical shis of
the linker ethylene glycol proton signals between the folded and
unfolded structure, and particularly the sharpening of the 1H
NMR peaks of chemosensor 2 upon unfolding.
Furthermore, absorbance and emission spectroscopy were
utilized because they allow for probing the supramolecular
behaviour of the chemosensors at several orders of magnitude
lower concentrations than NMR. The UV-Vis spectra of 1 in
water shows an indicative 5 nm bathochromic shi at 350 nm in
comparison to BC-HEG-N3 (Fig. 4a), which in analogy toThis journal is © The Royal Society of Chemistry 2020
Fig. 3 Overlay of 1H NMR (500 MHz, D2O) spectra of BC-HEG-N3 (bottom), chemosensor 1 (middle) and chemosensor 1 with one equivalent of
amantadine (top).
Fig. 4 (a) UV-Vis absorption spectra of BC-HEG-N3 and 1, each 5 mM
in water. Inset: fluorescence emission spectra (lex ¼ 350 nm) of 1 mM 1
before and after addition of 1.5 eq. amantadine in water. (b) Plot of
emission intensity at 540 nm in 140 mM NaCl and 5 mM phosphate
buffer versus concentration of CB7IBC complex (dashed line) and 1
(solid line), lex ¼ 350 nm; (c) plot of emission intensity at 540 nm of 1
mM CB7IBC complex (black) and 1 mM 1 (red) in water versus
concentration of NaCl, lex ¼ 350 nm. (d) Fitting plot of emission
intensity at 540 nm of 1 mM 1 in water (black) and 10 PBS (red) upon
addition of amantadine, lex ¼ 350 nm. Inset: chemosensor 1 upon
addition of spermine in the same media. Note: the individual data
points in (b and c) were connected by line segments to guide the eye
and do not represent fitting curves. 10 PBS is consisting of 1.37 M
NaCl, 27 mM KCl, 100 mM Na2HPO4 and 18 mM KH2PO4.

























































































View Article Onlineliterature reports44 suggests the inclusion of the BC chromo-
phore into the CB7 cavity also at the micromolar concentration
range. The emission spectra of 1 show a maximum at 540 nm by
excitation at 350 nm (Fig. 4a, inset). The addition of amantadine
leads to a strong decrease in emission intensity, indicative of
displacement of the BC moiety from the cavity of 1, because the
BC uorophore displays a much higher emission intensityThis journal is © The Royal Society of Chemistry 2020inside the hydrophobic CB7 cavity than in water.44 Likewise, the
emission intensity of the covalently bound CB7–dye conjugate 1
is a suitable indicator if the BC chromophore remains encap-
sulated by the host upon dilution. Indeed, we found a highly
linear curve of the emission intensity versus the concentration
of 1 even aer several times of dilution down to 30 nM (Fig. 4b,
solid line). In contrast, the intensity-concentration plot for the
non-covalent bimolecular CB7IBC complex showed a convex
curved shape because complex dissociation occurred at low
concentration, see dashed line in Fig. 4b. (In both experiments,
140 mM NaCl was used to weaken the CB7-BC binding
strength). Thus, also photophysical experiments conrm that
chemosensor 1 adopts a unimolecular, folded structure, as is
graphically depicted in Fig. 1a.Stability of CB7Idye complexes vs. chemosensor 1 in saline
media
As the basis for subsequent analyte detection studies, the
stability of our CB7-BC conjugates in saline media was investi-
gated. According to previous reports, the stability of many
CBnIdye complexes signicantly decreases in the presence of
salts, which reduces their utility for IDA sensing applica-
tions.17,24,44,51–54 Indeed, as shown in Fig. 4c (black line), the
presence of around 100 mM sodium chloride leads to complete
decomposition of the bimolecular CB7IBC assembly, which is
in accordance with our expectation as competitive binding of
metal cations to the carbonyl-fringed CBn portals occurs, e.g. Ka
¼ 2.57  103 M1 for CB7 with Na+.17 Clearly, the bimolecular
CB7IBC complex will therefore dissociate in biologically rele-
vant media such as biouids with typically high salt concen-
trations, e.g. 135–145 mM Na+ in plasma and 20–40 mM Na+ in
urine for healthy humans.55 In contrast, the residual uores-
cence intensity for chemosensor 1 remains at around 70% even
at 800 mM NaCl (Fig. 4c, red line). Note that the modestly
decreased emission intensity of 1 in saline media likely results
from the formation of 1INa+, where the BC moiety remains
encapsulated inside the CB7 cavity while the metal cationChem. Sci., 2020, 11, 11142–11153 | 11145

























































































View Article Onlineoccupies the opposite CB7-portal.18 (ESI-MS experiments gave
additional evidence that the binary complex of 1 with Na+ is
prominently present also in the gas-phase, which was the
species used for the ion-mobility studies.)Binding affinities of biorelevant analytes with the
chemosensors
The host–guest binding properties of chemosensors 1 and 2
were investigated in desalinated versus saline media. As repre-
sentative guests for CB7, several adamantyl derivatives (aman-
tadine, 1-adamantanol),25 polyamines (cadaverine, spermine,
spermidine)56 and steroids (nortestosterone)24 were selected
because of their known high binding affinities for CB7.
Expectedly, both chemosensor 1 and 2 respond with emis-
sion quenching upon addition of competitively binding guests
that displace the BC moiety from the cavity of the host; the
change in emission intensity is slightly larger for 2 than for 1
(see ESI† for details), pointing towards a small but signicant
effect of the linker length on structures adopted in solution.
Intriguingly, the binding curve of amantadine with 1 (Fig. 4d) or
2 (Fig. S35†) remains very steep even in 10 PBS, and binding
may be even stronger than in deionized water (Fig. S33 and S35†
in the ESI). Likewise, for the non-charged steroid nortestoster-
one, a very similar binding affinity with chemosensor 2 was
found in 10 PBS and water (Table 1 and Fig. S47†).
In contrast to the observation for amantadine or non-
charged guest, the polycationic guests cadaverine, spermine
and spermidine do not bind at all to our chemosensors in 10Table 1 Summary of the binding constants determined by fluores-
cence titration experiments with chemosensor 1 and 2 at 25 C. The




Amantadine Water 7.4 7.9 12.6c
1 PBS >8a >8a —
10 PBS >8a >8a —
Surine >8a >8a —
Cadaverine Water 3.7 4.0 8.4d
1 PBS 3.5 3.7 —
10 PBS <1b <1b —
Spermine Water 3.6 3.9 7.4e
1 PBS 3.4 3.6 —
10 PBS <1b <1b —
Spermidine Water 4.6 4.5 —
10 PBS <1b <1b —
1-Adamantanol 10 PBS >8a 7.5 —
Nortestosterone Water 4.5 4.5 7.1d
1 PBS 4.3 4.4 6.6f
10 PBS 4.1 4.8 —
a Lower estimate on the binding affinity, see Fig. S37 in the ESI.
b Binding affinity is too small to be determined by uorescence
titration. c Determined by NMR.58 d Determined with berberine as
indicator.24,59 e Determined with cyanostilbene as indicator.57
f Determined by isothermal titration calorimetry (ITC).24 1 PBS is
consisting of 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4 and
1.8 mM KH2PO4.
11146 | Chem. Sci., 2020, 11, 11142–11153PBS, while in deionized or minimal buffers, CB7 is a known
high-affinity binder of polyamines such as spermidine (Table
1).57 Indeed, also chemosensor 1 is responsive to polyamines in
deionized water (see Fig. S38–S43 in the ESI†). We found
binding affinities in a range of 103 to 105 M1 in the order
spermidine > cadaverine $ spermine (Table 1).
Moreover, the binding titrations indicated that TEG-linker-
based 2 forms a more strained folded conformation than
HEG-linker-based 1, as can be deduced from the observation
that the binding affinities of chemosensor 2 are slightly but
measurably higher than that of chemosensor 1 for the set of
guests studied.Binding kinetics of biorelevant analytes with the
chemosensors
Interesting features of the chemosensors were also found for
their binding kinetics: while amantadine, 1-adamantanol and
the polycationic amines are all relatively strongly bound in
water, the equilibration times follow the order polyamines (n+)
> amantadine (1+) [ 1-adamantanol/nortestosterone, ranging
from seconds (polyamines, amantadine) to several thousand of
seconds for non-charged guests, which points to a charge-
accelerating effect on the binding kinetics, see details in the
ESI.† It has been observed previously that positively charged
guests can form exclusion complexes prior to a ip-op-
mechanism into the cavity, which can speed up the binding
kinetics.60 In fact, the binding kinetics of 1-adamantanol was so
slow in desalinated water, as a result of which no binding
isotherms for Ka value determination could be obtained in
reasonable measurement times (Fig. 5a). In PBS, binding
kinetics of amantadine binding is much faster than in water
(Fig. 5), providing a practically convenient way to shorten assay
times through addition of salts. Notably, amantadine and 1-
adamantanol can still be readily distinguished based on their
kinetic prole, allowing for selective sensing of amantadine in
the presence of other non-charged high-affinity competitors
(Fig. 5c and e).
The kinetics studies also indicate modestly faster reaction
kinetics of 2 compared to 1, which is in accordance with an
energetically less-stable folded structure for the TEG-linked
chemosensor variant 2 (Fig. S48†).Features and fundamental limitations of non-covalent
CB7Idye reporter pairs
As an alternative to the use of a covalently dye–CB7 linked
unimolecular chemosensor, we assessed if the bimolecular
CB7Idye can be used for selective sensing of amantadine in
saline media and biouids (see next section) when suitable high
affinity dyes are used. Through the known binding affinities for
CB7 with metal cations, it is possible to estimate the apparent
binding constant of bimolecular CB7Iguest (and CB7Idye)
complexes in the presence of salts via
KCB7Iguest; saline media ¼ KCB7Iguest; water
1þ KCB7$Mþ ½Mþ0
for ½Mþ0[½CB70This journal is © The Royal Society of Chemistry 2020
Fig. 5 Fluorescence-based kinetic traces at 540 nm of 1.2 mM 2 and
2.09 mM amantadine (red) or 1-adamantanol (black) in (a) water, (c) 1
PBS and (e) 10 PBS at 25 C, lex ¼ 350 nm; fluorescence-based
kinetic traces at 454 nm of 1.8 mM MDAP, 1.2 mM CB7 and 2.09 mM
amantadine (red) or 1-adamantanol in (b) water, (d) 1 PBS and (f) 10
PBS at 25 C, lex ¼ 339 nm.

























































































View Article OnlineFor instance, with KCB7$Na+ ¼ 2.6  103 M1 for the
competitive interaction of Na+ with CB7,17 the affinity of CB7 for
amantadine still is expected as 1012 M1 in the presence of
220 mM Na+. Following our previous analysis for the design of
a CB8Idye IDA assay in biouids, one would therefore
conclude that indicator dyes within an affinity range of
KCB7Idye, saline media ¼ 107–1011 M1 may be ideally suited for
selectively detecting amantadine in the presence of salts and
other weaker binding interferents, e.g. biogenic amines.
However, this assumption turned out to be impractical:
(i) The lack of pH-unresponsive, high-affinity indicator dyes
for CB7 sets the rst “trivial” hindrance for establishing IDA-
based sensing assays for amantadine in biouids. MDAP is
one of the indicator dyes for CB7 with the highest Ka value, 2.7
 109 M1 in deionized water.18,61 Expectedly, its affinity to CB7
strongly drops with increasing salt content, reaching 1.8  106
M1, in 1 PBS (see Fig. S30† the ESI). In 10 PBS, its Ka value
became so weak (Ka ¼ 4.2  103 M1) that the CB7IMDAP
reporter pair cannot be used in the micromolar concentration
range (see Fig. S30† in the ESI). Consequently, the bimolecular
CB7IMDAP complex is applicable for amantadine detection in
saline media if they do not exceed the salt concentration of 1
PBS, however matrix effects will nevertheless be encountered if
the salinity signicantly differs between the biouid samples.This journal is © The Royal Society of Chemistry 2020In deionized water, the CB7IMDAP reporter pair shows like
the covalent chemosensors the ability to kinetically differentiate
the positively charged drug amantadine from the non-charged
analogue 1-adamantanol (Fig. 5b). However, the distinguish-
ability of amantadine and 1-adamantanol by CB7IMDAP is
much worsened upon increase of salinity to that of 1 PBS
(Fig. 5d). In 10 PBS, the detection of amantadine through
CB7IMDAP was not possible anymore due to disintegration of
the non-covalent host–dye complex (Fig. 5f). Furthermore, the
equilibration of amantadine with the CB7IMDAP complex is
much slower than with the unimolecular chemosensors,
causing longer assay times.
(ii) In order to overcome the affinity limitations of the
CB7IMDAP host–dye complex that lead to its susceptibility to
salts, we strove to develop a novel, pH-unresponsive, high-
affinity indicator dye for CB7. Taking into consideration the
strong binding affinities of adamantane for CB7,11,14,15 and the
favorable photophysical properties of stilbene-type dyes,17,41
DASAP (see Fig. 6 for chemical structure), was considered to be
a promising indicator dye, which could be obtained in 2 steps in
17.0% yield, see ESI.† DASAP showed promising properties as
an indicator dye for CB7, e.g. a 10-fold increase in its emission
intensity upon binding, a large Stokes shi (125 nm), a much
more red-shied absorption and emission spectra than MDAP,
and a steep binding isotherm with CB7 both in deionized water
and in 10 PBS (see Fig. S27† in the ESI). Its binding affinity to
CB7 was estimated to exceed 107 M1 even in 10 PBS. At rst
sight, one could believe that the desired non-pH dependent,
high-affinity dye for CB7 was found. However, its use proved to
be completely impractical in an IDA format; no signicant
change in the emission intensity of the CB7IDASAP complex
dissolved in water or 10 PBS was observed within 500 seconds
of assay time even upon addition of 100 excess of amantadine,
indicating that the CB7IDASAP complex is kinetically inert on
the practically relevant time scale (see Fig. S28† in the ESI).
Likewise, attempts to set up a guest-displacement-assay59 by
addition of DASAP to the pre-equilibrated CB7Iamantadine
complex failed, again due to a slow unbinding kinetics for high
affinity guests from CB7 (see Fig. S29† in the ESI).Chemosensor-based assay for the quantitative determination
of amantadine in urine and saliva
Motivated by the ability of our chemosensor to detect amanta-
dine even in ultra-high concentrated saline media (Fig. 4d and
S32,† about 1.37 M NaCl) in comparison with the ineffective-
ness of CB7IBC complexes in such environments, we trans-
ferred our binding studies rst to synthetic urine (“surine”) asFig. 6 Chemical structures of MDAP and DASAP.
Chem. Sci., 2020, 11, 11142–11153 | 11147

























































































View Article Onlinea well-dened media (see Fig. S50† in the ESI) and then to real
human urine and saliva.
Amantadine is typically prescribed in 100–200 mg daily
doses and is typically excreted by 15–50% unchanged in
urine.62,63 Thus, amantadine concentration of $40 mM will be
found for up to 24 h in urine. Following established routines for
spectroscopic urine diagnostics,19,20,64 urine samples were
diluted with water in a 1 : 4 ratio in order to reduce the absor-
bance of real urine and to avoid inner lter effects. As the
analyte concentration in urine samples is usually unknown, we
devised a new method for using chemosensor 1 for quantifying
amantadine in real urine samples. In short, chemosensors 1
and 2 were utilized as titrant to determine the amantadine
concentration in several real urine samples (Fig. 7a). In the
negative control sample (urine from a healthy donor that is not
receiving amantadine treatment), the addition of chemosensor
1 to the assay medium follows a linear plot, in accordance with
the proportional increase of the chemosensor concentration
(Fig. 7b). Thus, unfolding of the chemosensor does not occur in
the negative control medium, indicating that chemosensor 1 is
not affected by the components present in this urine sample.
Indeed, polyamines such as cadaverine and spermidine that are
present in human urine at a low micromolar concentration65
did clearly not unfold the chemosensor, which is in accordanceFig. 7 (a) Schematic representation of the analyte detection with
CB7–dye conjugate chemosensors in real urine media and simulation
of the trends in fluorescent intensity with increasing addition of
conjugate chemosensor; (b) fitting plot of the normalized emission
intensity at 540 nm versus concentration of 1 in 20% urine sample I;
fitting plot of the normalized emission intensity at 540 nm versus
concentration of 1 in 20% urine (c) sample I, (d) sample II and (e)
sample III with a final concentration of 2 mM amantadine at 25 C. This
corresponds to an amantadine concentration estimate of z10 mM in
the urine samples, which were indeed spiked with 10 mM amantadine.
11148 | Chem. Sci., 2020, 11, 11142–11153with their low binding affinity for the chemosensors in saline
media.
In order to simulate urine from Parkinson's patients
receiving amantadine treatment, urine samples from three
healthy donors were each spiked with 10 mM amantadine and
then diluted by water to reach a nal concentration of 2 mM
amantadine following the biological relevant concentration. As
can be seen in Fig. 7c–e, the uorescence intensity showed
a signicant two-stage distribution as a function of chemo-
sensor concentration. The amantadine concentration is ob-
tained by the intersect of the two straight lines described by two
sets of data points: (1) those obtained with titrant concentra-
tions under 1.0 equivalent and (2) those obtained with titrant
concentrations above 1.0 equivalent. Aer tting the two
different stages, the intersection was found at approx. 2 mM
amantadine in correspondence to the spiked amantadine
concentration of 2 mM in 4 : 1 diluted urine medium (and thus
10 mM amantadine in urine). To probe the inuence of sample-
to-sample matrix variations, experiments were carried out in
three different urine samples and gave in each instance the
anticipated result (Fig. 7c–e).
It should be noted that amantadine detection in surine was
also feasible through the CB7IMDAP reporter pair and the
simulated presence of biogenic amines, only modestly
disturbed the assay (Fig. S51 and S52†). However, the kinetics of
amantadine binding to CB7IMDAP is slower than for the
unimolecular chemosensors, and its susceptibility to interfer-
ence from salts or other CB7-binding compounds is higher.
Thus, it remains to be seen if the CB7IMDAP-based assay
remains reliable under practical conditions, i.e. in real urine
that contains varying concentrations of salts and organic
components (e.g. other drugs).
Aer oral administration, amantadine is also found in other
body uids, such as nasal, saliva and cerebrospinal uid
(CSF).66,67 For instance, the levels of amantadine in saliva equals
approximately those in the serum in the range of 0.3 mg mL1 to
0.8 mg mL1 (around 2 mM to 5 mM).68 However, saliva contains
much higher concentrations of biogenic amines (up to 400 mM
cadaverine)69 than urine while being less saline, which would
have caused undesirable interferences for indicator displace-
ment assays with non-covalent CB7Idye reporter pairs. Fortu-
nately, chemosensor 1 and 2 were found to be operational also
in human saliva: as qualitative testing, saliva sample from
a healthy donor was spiked with 5 mM chemosensor 1 and the
emission was recorded by a microplate reader prior and aer
spiking with 5 mM amantadine (Fig. 8a), resulting in the ex-
pected emission intensity decrease upon unfolding of the che-
mosensor in the presence of the drug. Note that this assay can
be performed directly in non-diluted saliva. Analogously to the
assay type introduced for quantication of amantadine in urine,
we also set to determine the amantadine concentration in non-
diluted saliva; we used again 2 mM of drug spiking as a presen-
tative showcase. Again, the expected amantadine concentration
was returned from our assay in three different saliva samples by
using chemosensor 1 and 2 (see Fig. 8b and S62–S69 in the
ESI†). Investigation of the reporter pair CB7IMDAP for
amantadine detection in articial saliva showed a comparableThis journal is © The Royal Society of Chemistry 2020
Fig. 8 (a) Normalized emission intensity at 540 nm of 5 mM chemo-
sensor 1 in human saliva prior and after addition of 5 mM amantadine.
Error bars represent the standard deviation of the mean (n ¼ 3). (b)
Fitting plot of the normalized emission intensity at 540 nm obtained by
the stepwise addition of 1 to saliva that was spiked with 2 mM aman-
tadine, see the ESI† for repetition experiments and controls.

























































































View Article Onlineperformance to that of the chemosensors, but the simulated
presence of cadaverine that can reach high micromolar
concentrations in the saliva for some patients69 showed
a stronger impact on CB7IMDAP than on 2 (see Fig. S70† in the
ESI).
Discussion
In this study, we designed and synthesized unimolecular che-
mosensors based on CB7–dye conjugates, which was inspired
by the seminal work on a covalent b-cyclodextrins (b-CD)-methyl
red chemosensors.70 The covalent linkage of an indicator dye to
the host by a exible tether is a promising approach towards
dilution-stable chemosensors. For instance, dansyl-appended
CD conjugates were synthesized and applied for detecting
peroxide explosives in aqueous media.71,72 Recently, a coumarin
labeled uorogenic probe was studied for evaluation of phos-
phatidylserine on cell surfaces by using an intramolecular
indicator displacement (IID) mechanism.73 Dilution-stable
unimolecular CBn–dye conjugates are attractive chemosensors
for diagnostics applications in biouids because cucurbit[n]uril
macrocycles (CBn, n ¼ 5–8, 10, 12), especially CB7, show high
binding affinities for several biologically relevant molecules in
aqueous media such as amino acids and their derivatives,
peptides, and drugs.11,14–16,21,74–76
Amantadine, which is a common drug to treat type A inu-
enza viruses77 and dyskinesia associated with Parkinson's
disease,78–80 is strongly bound to CB7 with affinities up to 1012
M1.58 In the particular case of amantadine, the line between
curing treatment and the occurrence of a series of side effects
due to the accumulation of amantadine in the human body is
narrow.81,82 Thus, the development of low-cost and widely
applicable methods (e.g. for point-of-care use) that enables the
routine quantication of the amantadine concentration in non-
invasively available biouids such as urine and saliva, may
enable individual drug-dose adjustments and could contribute
to improved life quality. To date, the most widely used detection
methods for amantadine are chromatographic methods such as
LC/GC/HPLC-MS,83–85 near-infrared spectroscopy,86 piezo-
electric immunosensor,87 and electrochemical techniques, e.g.,
potentiometry.88,89 Each of these methods has its strengths,This journal is © The Royal Society of Chemistry 2020however, all of them are largely constrained by complicating
and long-lasting operating procedures and expensive equip-
ment. Our emission-based supramolecular-analytical assay for
amantadine in urine and saliva can be readily performed and
does not require any sample pre-treatment steps. It is rapid,
cost-efficient and parallelizable and could revolutionize aman-
tadine sensing for drug dose adjustment in medical settings.
In the following, the herein utilized unimolecular chemo-
sensor design is compared to the much more frequently adop-
ted use of non-covalent, bimolecular reporter pairs:
(1) The increase of the affinity of the dye for the host through
covalent tethering, resulting in a higher degree of complexation
also in the presence of disruptive competitors, enables now the
use of intrinsically weakly binding indicator dyes that possess
desirable photophysical properties. In fact, non-charged or
monocationic CB7–indicator dyes such as berberine (BC),
cannot be used in biouids due to disintegration of their non-
covalent reporter pair complex, e.g. Ka ¼ 2.4  107 M1 for
CB7IBC in water but <1.9  105 M1 in the presence of 50 mM
NaCl.44 This restricted the choice of indicators to the few known
high-affinity dyes for CB7, which are mostly dicationic aromatic
species such as MDAP18,61 and 2,7-dimethyldiazaphenan-
threnium (MDPT),90 that due to their electron-poor and
symmetric structures possess rather unimpressive photo-
physical properties. For instance, this work demonstrated that
the CB7IMDAP reporter pair is functional for indicator
displacement assays in typical biorelevant saline buffer such as
1 PBS, where it retained a sufficiently high Ka value of 1.8 
106 M1. However, a higher salinity was not tolerated by this
reporter pair. From a photophysical point of view, MDAP is an
applicable uorophore (lem, max ¼ 454 nm), nevertheless, dyes
that absorb and emit in the visible region of the electromagnetic
spectrum are practically oen preferred. The herein advocated
host–dye conjugation strategy widens the scope of functional
chemosensors that can be prepared for use in (saline) aqueous
media by liing the previous constraints on searching for high-
affinity dyes that simultaneously possess desirable photo-
physical properties.
(2) Inspired by the reported adamantly-BODIPY conjugate
that functions as a pKa shi indicator dye for CB7,91 we devel-
oped a novel pH-independent push–pull type high-affinity
indicator dye (DASAP) for CB7 that functions both in water
and in strongly saline buffers. At rst, this design appeared to
have overcome both the affinity and the photophysical limits
encountered by MDAP, but practice uncovered a fundamental
limitation of indicator displacement assay-based sensing for
CB7Idye reporter pairs. Most indicator dyes reach a critical
length such that upon inclusion complex formation with CB7,
both portal regions of the hosts are occupied by the dye, as is
pictorially depicted in Fig. 9a. This structural feature is also
shared by the high-affinity CB7Idye complexes with dicationic
dyes and has critical implications on the equilibration times for
sensing assay times: in principle, the guest-exchange process
for host–guest complexes can occur through a SN1-type or SN2-
type-mechanism. For the example case of non-covalent
CB7Idye complexes, the SN1 mechanism appears to be the
main pathway,92 proceeding through the exit of the dye from theChem. Sci., 2020, 11, 11142–11153 | 11149
Fig. 9 (a) Schematic representation of a SN1-type-mechanism for the
guest-exchange process on analyte-induced conformational changes
of non-covalent CB7Idye reporter pair complexes; (b) schematic
representation of a SN2-type-mechanism for the guest-exchange
process on analyte-induced conformational changes of CB7–dye
conjugates.

























































































View Article Onlinehost as rst and rate limiting step (Fig. 9a). Conversely, a SN2-
type dye–guest exchange mechanism would require the forma-
tion of a guest$CB7$dye transient complex, whose formation is
impeded by the protruding indicator dye. (BC may be one
exception as the dye does not penetrate through the whole
cavity, allowing simultaneous binding of the dye and a cationic
species, e.g.metal ions.18 However, the CB7IBC complex is salt
labile and cannot be used in biouids, see the Results section).
Being limited to an SN1-type dye–guest exchange mechanism
for most CB7Idye reporter pair complexes, it becomes clear
that the higher the affinity of the dye for the host, the lower will
be the rate constant for the exit of the dye from the host because
kout ¼ kinKa1, and kin is relatively similar amongst different
guests for the same CBn homologue.18,92–94 These counteracting
effects result in a fundamental limitation for applying CBn-
based IDA for sensing applications in biouids with non-
covalent reporter pairs. On the one hand, the affinity of the
dye needs to be high enough to avoid disintegration of the
CBnIdye reporter pair in the presence of salts and other
competitively binding guests. While, on the other hand, high-
affinity dyes cause overall slowed down exchange kinetics,
which result in prolonged assay times. Note also that similar
rational holds for guest-displacement assays (GDA),59 which
likewise show impractically slow equilibration times for the
detection of high affinity guests such as amantadine, e.g. see the
Results section.
Indeed, while the thermodynamic and kinetic parameters of
the CB7IMDAP complex are fortunately counterbalanced (Ka ¼
2.7  109 M1, kin ¼ 2.4  107 M1 s1, kout ¼ 9.0  103 s1 in
water, see ref. 92), thereby enabling its practical use for sensing
applications in saline media and biouids, they also mark
a host–dye affinity limit beyond which assay performance will
drop because of a too slow exit of the dye from the host. For
instance, the high-affinity CB7IDASAP complex was found to
be impracticable as a reporter pair for the detection of aman-
tadine despite its excellent salt stability and favorable11150 | Chem. Sci., 2020, 11, 11142–11153photophysical properties. Similarly, our previously reported
CB8IMPCP reporter pair (Ka ¼ 3.9  1012 M1, kin ¼ 2.0  107
M1 s1, kout ¼ 5.1  106 s1 in water, see ref. 21 and 92) also
reached the limiting affinity region for non-covalent CB8Idye
reporter pairs, resulting in assay times of several minutes even
under the accelerating effect of salts present in biouids. It is
worth noting that CB8 has a lower inherent affinity to bio-
relevant metal cations such as Na+, K+ and Ca2+ than CB7,17 and
thus CB8Idye reporter pairs are less adversely affected by salts,
permitting the use of a lower affinity range for the reporter dye
than for the analogous CB7Idye reporter pairs in saline media.
Conversely, CB6-based chemosensing assays will likely not be
operational in biouids if non-covalent CB6Idye complexes
are used as the reporter pairs, because the ingression rates are
comparably low for CB6 complexes due to the constricted portal
region52,92 (thus limiting the acceptable affinity values for the
CB6Idye reporter pairs), while on the other hand CB6 has
a sizeable affinity for Na+, K+ and Ca2+.17 The covalent chemo-
sensor design overcomes these issues, and thus will be partic-
ularly attractive also for CB6-based chemosensors.
For chemosensors 1 and 2, the covalently-tethered indicator
dye BC does not protrude to both CB7 portals, but conversely
one CB7 portal region remains accessible, as was conrmed by
1H NMR experiments and molecular modelling. The situation is
graphically depicted in Fig. 9b and is consequence from the
choice of berberine as the indicator dye (that inherently does
not fully penetrate the CB7 cavity, see above) and from the
restricted linker lengths. Importantly, these covalently-linked
chemosensors possessing one accessible CB7-portal region
can form transient complexes with positively-charged guests
through cation–carbonyl interactions. Thus, the SN2 dye–guest
exchange pathway can be adopted by positively charged guests
such as amantadine, rationalizing much faster equilibration of
chemosensors 1 and 2 than of CB7IMDAP with this cationic
target analyte, and also explaining the large kinetic differences
observed between amantadine and 1-amantanol binding. The
covalent chemosensor design strategy thereby opens new
opportunities for improving the distinguishability of different
analytes through their characteristic binding kinetics. In this
study, different linker lengths of chemosensors 1 and 2 were
shown to give distinctly different structural, thermodynamic,
spectroscopic and kinetic behaviour in the gas phase and in
solution, suggesting that future exploration of the linker length
can be an additional chemosensor design-criterium, for
instance when indicator dyes other than berberine are used that
could penetrate fully into the host cavity.
Our study also revealed new supramolecular effects for CBn-
based host–guest complexes, e.g. the “expected” strongly
attenuated binding affinity of the chemosensors for polyamines
in saline buffer compared to the strengthening of the binding
for non-charged and mono-charged guests upon salinity
increase of the medium. Thus, practical assay performance –
e.g. in urine – can be improved by increase in the salinity of the
medium which at the same time will shorten the equilibration
times. Note that a similar strategy cannot be applied to the
CB7IMDAP (or CB7IBC) reporter pair-based assays becauseThis journal is © The Royal Society of Chemistry 2020

























































































View Article Onlinebinding strength of the bimolecular host–dye complex becomes
too weak in high salinity media.
Lastly, exploration of the characteristic effects on the ther-
modynamics and kinetics of analyte binding through addition
of salts to the assay medium will be useful for pattern
recognition-based differentiation of organic analytes.Conclusions
In this study, we designed and synthesized two novel CB7-based
unimolecular chemosensors, veried their conformation as
a back-folded unimolecular structure in the gas-phase and in
solution, and reported on their interaction with biologically
relevant molecules. Both conjugates displayed excellent resis-
tance to dilution and salt effects and remained functional
chemosensors even in 106 times excess of sodium chloride. In
biologically relevant buffered saline and even in real urine, the
chemosensors displayed a great selectivity for Parkinson's drug
amantadine over potential interferents such as polyamines (too
low affinity binding in saline media) or hydrophobic, non-
charged guests such as the steroid nortestosterone (very slow
binding). To the best of our knowledge, this is the rst CBn-
based unimolecular chemosensor that can be utilized for the
selective detection of a blockbuster drug, i.e. amantadine, in the
medically relevant concentration range in human urine and
saliva.95 While the non-covalent CB7IMDAP reporter pair also
may be a viable choice for amantadine detection in biouids,
this study nevertheless uncovered important and general
shortcomings of the use of high-affinity host–guest reporter
pairs, that will be even more limiting for CB6-based reporter
pairs. We believe that the covalent chemosensor design strategy
can overcome many of these limitations and can increase the
analyte-detection selectivity of the assays by providing access to
a SN2-type guest exchange mechanism.
The “chemosensor-standard-addition-method” that was
utilized here for amantadine quantication is particularly
useful because it circumvents the otherwise oen observed
matrix-to-matrix effects between different biouid specimens,
e.g. due to different colors, emission backgrounds or salinity of
urine samples. On account of the simplicity, cost-effectiveness
and speed of the supramolecular analytical method devel-
oped, it may nd future use in established diagnostic labora-
tories or point-of-care applications.Conflicts of interest
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8 M. A. Beatty, J. Borges-González, N. J. Sinclair, A. T. Pye and
F. Hof, J. Am. Chem. Soc., 2018, 140, 3500–3504.
9 Y. Liu, L. Perez, M. Mettry, C. J. Easley, R. J. Hooley and
W. Zhong, J. Am. Chem. Soc., 2016, 138, 10746–10749.
10 Z. Zheng, W.-C. Geng, J. Gao, Y.-Y. Wang, H. Sun and
D.-S. Guo, Chem. Sci., 2018, 9, 2087–2091.
11 S. Sinn and F. Biedermann, Isr. J. Chem., 2018, 58, 357–412.
12 J. Lagona, P. Mukhopadhyay, S. Chakrabarti and L. Isaacs,
Angew. Chem., Int. Ed., 2005, 44, 4844–4870.
13 R.-C. Mutihac, A. A. Bunaciu, H.-J. Buschmann and
L. Mutihac, J. Inclusion Phenom. Macrocyclic Chem., 2020,
DOI: 10.1007/s10847-020-01019-5.
14 K. I. Assaf andW.M. Nau, Chem. Soc. Rev., 2015, 44, 394–418.
15 S. J. Barrow, S. Kasera, M. J. Rowland, J. del Barrio and
O. A. Scherman, Chem. Rev., 2015, 115, 12320–12406.
16 D. Shetty, J. K. Khedkar, K. M. Park and K. Kim, Chem. Soc.
Rev., 2015, 44, 8747–8761.
17 S. Zhang, L. Grimm, Z. Miskolczy, L. Biczók, F. Biedermann
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P. Riederer, Eur. J. Pharmacol., Mol. Pharmacol. Sect., 1991,
206, 297–300.
81 F. G. Hayden, Antiviral Res., 2006, 71, 372–378.
82 G. He, J. Qiao, C. Dong, C. He, L. Zhao and Y. Tian, Antiviral
Res., 2008, 77, 72–76.
83 A. Bhadoriya, S. Rathnam, B. Dasandi, D. Parmar, M. Sanyal
and P. S. Shrivastav, J. Pharm. Anal., 2018, 8, 202–207.
84 A. Siou and F. Pommier, J. Chromatogr. B: Biomed. Sci. Appl.,
1980, 183, 33–39.This journal is © The Royal Society of Chemistry 202085 T.-H. Duh, H.-L. Wu, C.-W. Pan and H.-S. Kou, J. Chromatogr.
A, 2005, 1088, 175–181.
86 Y. Dou, Y. Sun, Y. Ren, P. Ju and Y. Ren, J. Pharm. Biomed.
Anal., 2005, 37, 543–549.
87 Y. Yun, M. Pan, L. Wang, S. Li, Y. Wang, Y. Gu, J. Yang and
S. Wang, Anal. Bioanal. Chem., 2019, 411, 5745–5753.
88 N. T. Abdel-Ghani, A. F. Shoukry and S. H. Hussein, J. Pharm.
Biomed. Anal., 2002, 30, 601–611.
89 F. Jalali and R. Maghooli, Anal. Sci., 2009, 25, 1227–1230.
90 Y. Ling, W. Wang and A. E. Kaifer, Chem. Commun., 2007,
610–612.
91 M. A. Alnajjar, J. Bartelmeß, R. Hein, P. Ashokkumar,
M. Nilam, W. M. Nau, K. Rurack and A. Hennig, Beilstein J.
Org. Chem., 2018, 14, 1961–1971.
92 A. Prabodh, S. Sinn, L. Grimm, Z. Miskolczy, M. Megyesi,
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